Retatrutide Weekly Dosing Studied in Obese Patients with Knee Osteoarthritis | Retatrutide News

A study on retatrutide's safety and efficacy in obese patients with knee osteoarthritis has been completed. The trial lasted about 77 weeks, focusing on...
Clinical Trials · November 3, 2026